The Use of Lanreotide Autogel® in the Treatment of Intestinal Obstruction in a Patient with Adenocarcinoma

Publisher： Karger

E-ISSN： 1662-6575|7|1|43-46

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.7, Iss.1, 2014-01, pp. : 43-46

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lanreotide Autogel®® in acromegaly and neuroendocrine tumors

By Caron Philippe  

Therapy, Vol. 4, Iss. 1, 2007-01 ,pp. : 9-29

Future Medicine

Access to resources Recommend Favorite

Pseudomyxoma Peritonei: Symptom Control and Objective Radiological Response after Treatment with Lanreotide Autogel

By  

Case Reports in Oncology, Vol. 9, Iss. 1, 2016-01 ,pp. : 56-61

Karger

Access to resources Recommend Favorite

THE TREATMENT OF INTESTINAL OBSTRUCTION IN THE AGED†

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 3, Iss. 12, 1955-12 ,pp. : 974-983

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-Term Disease Control of a Pancreatic Neuroendocrine Tumor with Lanreotide Autogel®: A Case Report

By  

Case Reports in Oncology, Vol. 7, Iss. 3, 2014-09 ,pp. : 673-680

Karger

Access to resources Recommend Favorite

INTESTINAL OBSTRUCTION IN THE AGED*

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 1, Iss. 3, 1953-03 ,pp. : 205-212

John Wiley & Sons Inc

Access to resources Recommend Favorite